TR201901771T4 - Memelilerde kemik kaybının önlenmesi veya tedavi edilmesinde kullanıma yönelik lactobacillus reuteri ATCC PTA 6475. - Google Patents
Memelilerde kemik kaybının önlenmesi veya tedavi edilmesinde kullanıma yönelik lactobacillus reuteri ATCC PTA 6475. Download PDFInfo
- Publication number
- TR201901771T4 TR201901771T4 TR2019/01771T TR201901771T TR201901771T4 TR 201901771 T4 TR201901771 T4 TR 201901771T4 TR 2019/01771 T TR2019/01771 T TR 2019/01771T TR 201901771 T TR201901771 T TR 201901771T TR 201901771 T4 TR201901771 T4 TR 201901771T4
- Authority
- TR
- Turkey
- Prior art keywords
- bone loss
- base pair
- mammals
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261689338P | 2012-06-04 | 2012-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201901771T4 true TR201901771T4 (tr) | 2019-03-21 |
Family
ID=49712339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/01771T TR201901771T4 (tr) | 2012-06-04 | 2013-06-04 | Memelilerde kemik kaybının önlenmesi veya tedavi edilmesinde kullanıma yönelik lactobacillus reuteri ATCC PTA 6475. |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US20150150917A1 (enExample) |
| EP (2) | EP2854826B9 (enExample) |
| JP (1) | JP6193981B2 (enExample) |
| KR (2) | KR102191537B1 (enExample) |
| CN (1) | CN104755091B (enExample) |
| AU (2) | AU2013272330B2 (enExample) |
| CA (1) | CA2875841C (enExample) |
| DK (2) | DK3456334T3 (enExample) |
| ES (2) | ES2847424T3 (enExample) |
| HR (1) | HRP20190162T1 (enExample) |
| HU (1) | HUE042643T2 (enExample) |
| LT (1) | LT2854826T (enExample) |
| PL (2) | PL2854826T3 (enExample) |
| SI (1) | SI2854826T1 (enExample) |
| TR (1) | TR201901771T4 (enExample) |
| WO (1) | WO2013184064A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101915904B1 (ko) | 2016-08-12 | 2018-11-06 | 한국식품연구원 | 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물 |
| KR102120479B1 (ko) * | 2018-10-30 | 2020-06-09 | 주식회사 종근당바이오 | 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물 |
| US12427174B2 (en) * | 2019-02-05 | 2025-09-30 | Biomedit, Inc. | Probiotic compositions comprising lactobacillus reuteri strains and methods of use |
| KR102080498B1 (ko) * | 2019-08-23 | 2020-02-24 | 정영옥 | 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물 |
| JP7596301B2 (ja) * | 2019-12-02 | 2024-12-09 | 雪印メグミルク株式会社 | 骨強化剤 |
| CN111718903A (zh) * | 2020-06-24 | 2020-09-29 | 江南大学 | 一种筛选可预防和/或治疗骨质疏松的药物的方法 |
| CN114711429B (zh) * | 2021-06-08 | 2023-11-17 | 青岛蔚蓝生物股份有限公司 | 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用 |
| CN114634901B (zh) * | 2022-05-18 | 2022-08-30 | 微康益生菌(苏州)股份有限公司 | 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用 |
| KR102937770B1 (ko) * | 2023-08-09 | 2026-03-12 | 국립한국교통대학교산학협력단 | 골다공증 억제 균주 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1511502A2 (en) * | 2002-06-13 | 2005-03-09 | Alimentary Health Limited | Probiotic therapies using lactobacillus reuteri |
| US7344867B2 (en) * | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| EP1918373B1 (en) * | 2005-07-26 | 2014-08-20 | Nestec S.A. | Anti-obesity agent and anti-obesity food |
| WO2008028300A1 (en) * | 2006-09-07 | 2008-03-13 | Mcgill University | Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
-
2013
- 2013-06-04 HU HUE13800449A patent/HUE042643T2/hu unknown
- 2013-06-04 DK DK18202594.0T patent/DK3456334T3/da active
- 2013-06-04 CA CA2875841A patent/CA2875841C/en active Active
- 2013-06-04 EP EP13800449.4A patent/EP2854826B9/en active Active
- 2013-06-04 LT LTEP13800449.4T patent/LT2854826T/lt unknown
- 2013-06-04 PL PL13800449T patent/PL2854826T3/pl unknown
- 2013-06-04 SI SI201331342T patent/SI2854826T1/sl unknown
- 2013-06-04 WO PCT/SE2013/050646 patent/WO2013184064A1/en not_active Ceased
- 2013-06-04 HR HRP20190162TT patent/HRP20190162T1/hr unknown
- 2013-06-04 US US14/405,496 patent/US20150150917A1/en not_active Abandoned
- 2013-06-04 AU AU2013272330A patent/AU2013272330B2/en not_active Ceased
- 2013-06-04 DK DK13800449.4T patent/DK2854826T3/en active
- 2013-06-04 KR KR1020207011037A patent/KR102191537B1/ko active Active
- 2013-06-04 TR TR2019/01771T patent/TR201901771T4/tr unknown
- 2013-06-04 PL PL18202594T patent/PL3456334T3/pl unknown
- 2013-06-04 CN CN201380029676.7A patent/CN104755091B/zh not_active Expired - Fee Related
- 2013-06-04 EP EP18202594.0A patent/EP3456334B1/en active Active
- 2013-06-04 JP JP2015515983A patent/JP6193981B2/ja active Active
- 2013-06-04 ES ES18202594T patent/ES2847424T3/es active Active
- 2013-06-04 ES ES13800449T patent/ES2711427T3/es active Active
- 2013-06-04 KR KR1020147036636A patent/KR20150028968A/ko not_active Ceased
-
2016
- 2016-10-21 US US15/331,346 patent/US9968643B2/en active Active
-
2018
- 2018-01-23 AU AU2018200524A patent/AU2018200524B2/en not_active Ceased
- 2018-03-12 US US15/918,207 patent/US10232001B2/en active Active
-
2019
- 2019-01-23 US US16/254,994 patent/US10537598B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
| PH12019502725A1 (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
| MY181102A (en) | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | |
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| MX368346B (es) | Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas. | |
| EP3409666A3 (en) | Seca inhibitors and methods of making and using thereof | |
| BR112014030202A2 (pt) | microorganismos e métodos para a produção de 4-hidroxibutirato 1,4-butanodiol e compostos relacionados | |
| BR112013011263A2 (pt) | "composição nematicida, e método para controlar nematódeos" | |
| MX340533B (es) | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. | |
| IN2012DN01638A (enExample) | ||
| BR112013000097A2 (pt) | composições e métodos relacionados a variantes da proteína a (spa) | |
| CY1113187T1 (el) | Απομονωμενο στελεχος του μικροοργανισμου lactobacillus plantarum tensia dsm 21380 ως αντιμικροβιακο και αντιυπερτασικο προβιοτικο, τροφιμο και συνθεση που περιλαμβανει τον εν λογω μικροοργανισμο και χρηση του εν λογω μικροοργανισμου για την παρασκευη ενος αντιυπερτασικου φαρμακου και μεδοθος για την καταστολη των παθογονων και των γαλακτοβακιλλων που δεν χρησιμοποιουνται ως ζυμη μεσα σε ενα τροφιμο | |
| MX2015014896A (es) | Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biologico que las contienen. | |
| MX2012013834A (es) | Cepas probioticas para mejorar el sistema nervioso enterico. | |
| MY184865A (en) | Novel bacillus subtilis | |
| UA113399C2 (xx) | Штам непатогенної грамнегативної бактерії та його застосування в дерматології | |
| PH12015501273A1 (en) | Probiotic strains for the treatment and/or prevention of diarrhea | |
| PH12015502375A1 (en) | Antimicrobial compounds and methods of making and using the same | |
| MX2010003719A (es) | Vacuna de mycoplasma bovis y metodos de uso de la misma. | |
| MX2017015674A (es) | Suplemento dietetico. | |
| UA118339C2 (uk) | Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти) | |
| MX393266B (es) | Composiciónpara usarse en terapia de microbiota | |
| WO2018004224A3 (ko) | 신규 스포리치아과 미생물 및 그의 용도 | |
| EA201291440A1 (ru) | Пробиотические штаммы для применения при повышении трансэпителиального сопротивления | |
| MY197917A (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus |